Skip to main navigation
Skip to search
Skip to main content
Northwestern Scholars Home
Help & FAQ
Home
Experts
Organizations
Research Output
Grants
Core Facilities
Research Data
Search by expertise, name or affiliation
Prot #VX20-121-102: A Phase 3, Randomized, Double-blind, Controlled Study Evaluating the Efficacy and Safety of VX-121 Combination Therapy in Subjects With Cystic Fibrosis Who Are Heterozygous for F508del and a Minimal Function Mutation (F/MF)
Jain, Manu
(PD/PI)
Medicine, Pulmonary Division
Project
:
Research project
Overview
Project Details
Status
Active
Effective start/end date
12/13/21
→
6/30/25
Funding
Vertex Pharmaceuticals Incorporated
((OE) Prot #VX20-121-102)
View all
View less